S2Medical AB (S2M) — Capital Reinvestment Ratio
S2Medical AB (S2M) has a Capital Reinvestment Ratio of 2.99x as of December 2025, meaning it reinvests 3% of its operating cash flow (Skr676.00K) in capital expenditures (Skr2.02 Million). See S2Medical AB (S2M) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
S2Medical AB Capital Reinvestment Ratio (2024–2025)
This chart tracks S2Medical AB's Capital Reinvestment Ratio across 2 annual periods. Check S2Medical AB (S2M) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for S2Medical AB (2024–2025)
Year-by-year Capital Reinvestment Ratio for S2Medical AB from 2024 to 2025. For live market cap and broader valuation context, see market value of S2Medical AB.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr675.00K | Skr675.00K | ▲ +693.5% |
| 2024 | 0.13x | Skr5.03 Million | Skr634.00K | — |